Man Group plc Makes New Investment in Cabot Corporation $CBT

Man Group plc acquired a new stake in shares of Cabot Corporation (NYSE:CBT) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 47,451 shares of the specialty chemicals company’s stock, valued at approximately $4,310,000. Man Group plc owned approximately 0.09% of Cabot as of its most recent SEC filing.

Other institutional investors and hedge funds have also modified their holdings of the company. Rothschild Investment LLC raised its position in shares of Cabot by 170.4% during the 4th quarter. Rothschild Investment LLC now owns 411 shares of the specialty chemicals company’s stock worth $27,000 after purchasing an additional 259 shares during the last quarter. Northwestern Mutual Wealth Management Co. acquired a new stake in Cabot in the 2nd quarter worth about $33,000. Global Retirement Partners LLC increased its stake in Cabot by 1,606.9% during the 4th quarter. Global Retirement Partners LLC now owns 495 shares of the specialty chemicals company’s stock worth $33,000 after buying an additional 466 shares in the last quarter. Geneos Wealth Management Inc. increased its stake in Cabot by 409.0% during the 1st quarter. Geneos Wealth Management Inc. now owns 453 shares of the specialty chemicals company’s stock worth $38,000 after buying an additional 364 shares in the last quarter. Finally, Danske Bank A S acquired a new position in shares of Cabot during the third quarter valued at approximately $38,000. Hedge funds and other institutional investors own 93.18% of the company’s stock.

Cabot Price Performance

CBT stock opened at $83.67 on Monday. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.47 and a quick ratio of 0.97. The business has a 50 day simple moving average of $87.62 and a 200-day simple moving average of $81.24. The firm has a market capitalization of $4.32 billion, a PE ratio of 23.57, a price-to-earnings-growth ratio of 10.98 and a beta of 0.84. Cabot Corporation has a 1 year low of $58.33 and a 1 year high of $94.53.

Cabot (NYSE:CBT) last announced its quarterly earnings data on Monday, August 3rd. The specialty chemicals company reported $1.67 EPS for the quarter, topping analysts’ consensus estimates of $1.66 by $0.01. The firm had revenue of $982.00 million for the quarter, compared to the consensus estimate of $943.16 million. Cabot had a return on equity of 20.29% and a net margin of 5.23%.The firm’s revenue was up 6.4% compared to the same quarter last year. During the same quarter last year, the business posted $1.90 earnings per share. Cabot has set its FY 2026 guidance at 6.150-6.450 EPS. Equities research analysts anticipate that Cabot Corporation will post 6.35 earnings per share for the current fiscal year.

Cabot Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, September 11th. Stockholders of record on Friday, August 28th will be issued a dividend of $0.4725 per share. This represents a $1.89 annualized dividend and a dividend yield of 2.3%. The ex-dividend date is Friday, August 28th. Cabot’s payout ratio is currently 53.24%.

Insider Activity at Cabot

In other news, CEO Sean D. Keohane sold 91,923 shares of the business’s stock in a transaction dated Friday, August 7th. The shares were sold at an average price of $86.41, for a total transaction of $7,943,066.43. Following the transaction, the chief executive officer owned 404,134 shares of the company’s stock, valued at approximately $34,921,218.94. The trade was a 18.53% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. 3.08% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

A number of brokerages have recently issued reports on CBT. JPMorgan Chase & Co. lifted their price target on Cabot from $70.00 to $78.00 and gave the stock an “underweight” rating in a research note on Friday, August 7th. Mizuho raised their price objective on Cabot from $80.00 to $90.00 and gave the company a “neutral” rating in a report on Thursday, June 25th. Wall Street Zen raised shares of Cabot from a “hold” rating to a “buy” rating in a research note on Sunday, August 9th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Cabot in a report on Friday, August 21st. Finally, Truist Financial set a $100.00 target price on shares of Cabot in a research report on Wednesday, August 5th. Two investment analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Hold” and an average price target of $89.00.

Cabot Profile

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.